ecteinascidin 743 has been researched along with Leukemia, Myelomonocytic, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allavena, P; Bello, E; Biondi, A; Bonetti, E; Cazzola, M; Craparotta, I; D'Incalci, M; Della Porta, MG; Erba, E; Gallì, A; Galmarini, CM; Licandro, SA; Locatelli, F; Mannarino, L; Marchini, S; Panini, N; Porcu, L; Rambaldi, A; Romano, M; Rossi, M; Rosti, V; Tancredi, R; Zambelli, A; Zecca, M | 1 |
1 other study(ies) available for ecteinascidin 743 and Leukemia, Myelomonocytic, Chronic
| Article | Year |
|---|---|
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cell Proliferation; Dioxoles; Female; Gene Expression Profiling; Humans; Leukemia, Myelomonocytic, Chronic; Leukemia, Myelomonocytic, Juvenile; Mice; Mice, Nude; Myelodysplastic Syndromes; Tetrahydroisoquinolines; Trabectedin; Tumor Stem Cell Assay | 2017 |